TECHNVISNBSETechNVision Ventures LtdLowNeutral
Announced Tue, 2 Jun · 15:53 IST

Please find the attached announcement for dissemination at the corporate announcement section of BSE.

Management Changes View source PDF

TECHNVISN · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+0.9%1-day move
₹5400.00
prior close
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.9+2.8+1.7+1.3+0.4+0.9-7.4-25.9
Up moveDown movePending
AI summary

TechNVision Ventures Ltd has submitted a news item to BSE for dissemination regarding its affiliate Solix Technologies' appointment of Dr. Ujwala as Director of Technical Product Management. She brings over 22 years of experience across pharmaceutical R&D, clinical research, pharmacovigilance, regulatory operations, and AI-driven digital transformation. Based in Mumbai, she will lead product roadmap strategy and business development for Solix's Life Sciences and AI initiatives across India and North America. Previously, she spent a decade building Mumbai-based CRO Nucleon Research. Solix Technologies is an affiliate of TechNVision Ventures Ltd and provides enterprise data and AI platform solutions.

Likely market impact

This is a PR dissemination about an affiliate (Solix Technologies), not a change at TechNVision Ventures itself, so direct impact on the listed entity's stock or shareholders is limited. However, it highlights the affiliate's strategic push into AI-powered Life Sciences solutions, which is a positive growth signal for the group's overall direction.